With limited lab requirements, minimal provider interaction, and a heavy reliance on compounded medications, Hers falls short on safety oversight and long-term support
Its approved to treat adults and pediatric patients 12 years and older with obesity who weigh more than 60 kg (132 pounds)
Changes in circulating levels of LDL-C, high-density lipoprotein cholesterol and free fatty acids were not statistically different between various patient groups in the diabetes study [4]
September 1, 2025 Teva Pharmaceuticals achieved a landmark milestone when the US Food and Drug Administration (FDA) approved a first-of-its-kind launch of a generic glucagon-like peptide-1 (GLP-1)
The combination of slowing digestion, reducing blood sugar, and decreasing appetite helps weight loss
Of course, there may be factors influencing weight-loss outcomes